PHARMA

Quarterly rpt on consolidated results for the financial period ended 31/12/2011

Amended Announcements
Please refer to the earlier announcement reference number: PB-120220-40927

PHARMANIAGA BERHAD

Financial Year End

31/12/2011
Quarter4
Quarterly report for the financial period ended31/12/2011
The figureshave not been audited

Attachments

KLSE1112 amended.pdf
254 KB


Remarks :
1. Dividend for current quarter of 30 sen comprises:-
i) Interim Dividend of 9 sen per share, less taxation of 25% declared for 4th quarter ended 31 December 2011 which was paid on 26 January 2012.
ii) Single tier dividend of 21 sen per share declared for 4th quarter ended 31 December 2011 payable on 28 March 2012.

2. The Basic Earnings per Share ("EPS") were calculated based on weighted average number of shares inclusive of bonus issue as approved by the Board on 22 December 2011 and subsequently completed on 20 February 2012. The EPS for the preceding year corresponding quarter and year have been restated to reflect the retrospective adjustments arising from the aforementioned bonus issue.
  • Default Currency
  • Other Currency

Currency: Malaysian Ringgit (MYR)

SUMMARY OF KEY FINANCIAL INFORMATION
31/12/2011

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
31/12/2011
31/12/2010
31/12/2011
31/12/2010
$$'000
$$'000
$$'000
$$'000
1Revenue
367,786
376,116
1,520,981
1,378,348
2Profit/(loss) before tax
16,368
-2,701
73,186
45,462
3Profit/(loss) for the period
12,182
-1,952
52,785
30,310
4Profit/(loss) attributable to ordinary equity holders of the parent
11,942
-2,256
52,157
30,384
5Basic earnings/(loss) per share (Subunit)
10.15
-1.92
44.32
25.82
6Proposed/Declared dividend per share (Subunit)
30.00
0.00
30.00
10.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
4.3700
3.9400

Remarks :
Amendment to item No. 6:

The individual and cumulative quarter for the current year to date proposed/declared dividend per share (subunit) should state 30.00 instead of 21.00, taking into account the earlier dividend of 9.00 sen per share paid on 26 January 2012.

Amendments to the Notes:

B21. In line 2 in previous disclosure, "In this respect, BHB will undertake restricted offer for sale of ...." should read "In this respect, BHB will undertake divestment of shares of....."

B28. In previous disclosure, the weighted average number of ordinary shares in issue ('000) was "117,676" should read "117,674".
In line 2 in previous disclosure, "arising from Bonus Issue of 10,697,800 shares..." should read "arising from actual Bonus Issue of 10,696,181 shares as mentioned in Note B21 (ii)."
Definition of Subunit:

In a currency system, there is usually a main unit (base) and subunit that is a fraction amount of the main unit.
Example for the subunit as follows:

CountryBase UnitSubunit
MalaysiaRinggitSen
United StatesDollarCent
United KingdomPoundPence


Announcement Info

Company NamePHARMANIAGA BERHAD  
Stock Name PHARMA    
Date Announced22 Feb 2012  
CategoryFinancial Results
Reference NoPB-120222-ECBF9